MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Hypothalamic Atrophy in CANVAS/RFC1

C. Lobo, V. Souza, T. Rezende, J. Neiva, P. Matos, F. Lima, A. Martinez, O. Barsottini, J. Pedroso, W. Marques Jr, M. França Jr (Campinas, SP, Brazil)

Meeting: 2025 International Congress

Keywords: Ataxia: Clinical features, Dysautonomia(see autonomic dysfunction), Magnetic resonance imaging(MRI)

Category: Ataxia

Objective: We aimed to investigate hypothalamic volumetry in CANVAS/RFC1.

Background: Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) is now recognized as a late-onset multisystem neurodegenerative disorder. While dysautonomia and sleep disturbances suggest hypothalamic involvement, no studies have assessed hypothalamic structural changes in CANVAS.

Method: We analyzed 38 individuals (19 CANVAS patients, 19 age- and sex-matched healthy controls) using automated hypothalamic segmentation tool (H-SynEx) from 3T MRI scans. Volumetric comparisons were performed using ANCOVA with correction for multiple comparisons. Pearson’s correlation was applied to assess correlation between hypothalamic volumes and clinical parameters (SARA and SCOPA-AUT scores).

Results: Patients with CANVAS/RFC1 have a significantly lower total hypothalamic volume (RFC1: 734.84 ±160.49 mm³ vs Controls: 878.83 ±136.55 mm³; P = 0.03; d = 0.99) and a reduced left tuberal superior (LTS) volume (RFC1: 71.21 ±21.85 mm³ vs Controls: 90.30 ±15.67 mm³; P= 0.02; d = 0.99) compared to the control group. An inverse correlation was observed between LTS volume and SARA score in CANVAS/RFC1 patients (R=-0.51; P=0.049). No significant associations were found between hypothalamic volume and SCOPA-AUT scores or disease duration.

Conclusion: This is the first study to demonstrate hypothalamic atrophy in CANVAS, highlighting its potential role in disease pathophysiology. Future studies should explore broader hypothalamic dysfunctions and their clinical implications.

To cite this abstract in AMA style:

C. Lobo, V. Souza, T. Rezende, J. Neiva, P. Matos, F. Lima, A. Martinez, O. Barsottini, J. Pedroso, W. Marques Jr, M. França Jr. Hypothalamic Atrophy in CANVAS/RFC1 [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/hypothalamic-atrophy-in-canvas-rfc1/. Accessed October 6, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/hypothalamic-atrophy-in-canvas-rfc1/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley